Standout Papers
Immediate Impact
4 by Nobel laureates 3 from Science/Nature 89 standout
Citing Papers
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD
2025 Standout
Works of Adrien Guillot being referenced
Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages☆
2020 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Adrien Guillot | 872 | 535 | 467 | 51 | 1.6k | |
| Salvatore Sutti | 1111 | 539 | 387 | 49 | 1.7k | |
| Xiaodong Ge | 614 | 418 | 409 | 38 | 1.4k | |
| Pierluigi Ramadori | 628 | 395 | 622 | 42 | 1.7k | |
| Seonghwan Hwang | 824 | 300 | 558 | 49 | 1.6k | |
| Christophe Van Steenkiste | 816 | 691 | 428 | 67 | 1.6k | |
| Norio Horiguchi | 940 | 652 | 468 | 67 | 2.0k | |
| Yukinori Koyama | 1193 | 1083 | 465 | 52 | 2.1k | |
| Dick Knook | 466 | 491 | 501 | 52 | 1.7k | |
| Yulia A. Nevzorova | 701 | 479 | 561 | 48 | 1.5k | |
| Ricard Masia | 790 | 418 | 587 | 72 | 2.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...